ORGANIZATION OF INTENSIVE CARE SERVICE FOR PATIENTS WITH COVID-19 DURING PANDEMIC IN ALMATY CITY
Since the beginning of the new coronavirus infection pandemic over 102.5 million people have been infected and over 2.2 million have died. The world statistics on COVID-19 rates Kazakhstan as 59 with revealed cases of COVID-19 and 68 with deaths cases.
In 80% of patients with COVID-19, COVID-19 have mild or moderate disease, about 15% have severe disease requires oxygen support, and 5% have a critical illness requires stay in intensive care units. The average duration of ICU stay is 10.8 days. In 22.7% of patients, ICU length of stay is over 30 days. The mortality rate of patients in intensive care units was 40-61% during the first wave, but in most affected regions it was as high as 90%.
In order to improve the results of intensive care, a team-based way introduced in many hospitals. These teams do most labor-consuming and potentially dangerous manipulations. This approach requires a sufficient number of engaged and well-trained staff.
In in an acute shortage of ICU staff, some actions assumed to train medical personnel of other specialties to become doctors and nurses in intensive care units. Short and superficial courses, designed to prepare the maximum number of intensive care specialists in the shortest time, as a rule, leads to a deterioration in the quality of the provided intensive care and does not improve results and mortality.
Number of Views: 148
Category of articles:
COVID-19 - Topical Subject
Bibliography link
Kuandykov T., Mutagirov V., Seiduanova L. Organization of intensive care service for patients with COVID-19 during pandemic in Almaty City // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp.27-32. doi 10.34689/SH.2022.24.4.004Related publications:
EPIDEMIOLOGICAL ASPECTS OF IN-STENT THROMBOSIS AND RESTENOSIS OF CORONARY ARTERIES IN PATIENTS WITH PREVIOUS REVASCULARIZATION AFTER CORONAVIRUS INFECTION
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
APPLICATION OF ARTIFICIAL INTELLIGENCE IN COMBATING THE COVID-19 PANDEMIC: CURRENT TRENDS AND PROSPECTS. REVIEW
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW